Tuesday, April 7, 2015

A Trio of Biotech Favorites: PCYC, ABBV, TEVA, NVAX, MDCO

Our guest today is Jay Silverman, a leading biotechnology sector analyst and editor of The Medical Technology Stock Letter. He updates us on the acquisition of one of his long-standing recommendations, the impact of this deal on the biotech space, and a trio of additional ideas for long-term investors to consider.

Steven Halpern: Our guest today is Jay Silverman, biotechnology sector analyst and editor of The Medical Technology Stock Letter.  How are you doing today, Jay?

Jay Silverman: I’m great, Steve. Thanks a lot.

Steven Halpern: Well, first off, kudos are in order.  In previous conversations with MoneyShow, you’ve highlighted Pharmacyclics (PCYC) as one of your favorite biotech investments, and, in fact, have recommended the stock several times for our listeners at prices around $100 a share. Now the stock is about $250.  Could you update our listeners on the developments and what caused the sharp price increase? (more)

Please share this article

Tesla Shares TSLA SurgE After Strong Sales and Bullish Comments From Analysts

Shares of Tesla are surging over 8 percent after the company reported strong vehicle sales in the first quarter on Friday.
Tesla delivered 10,030 vehicles during the first quarter, beating previous guidance of 9500. Analysts were praising the report, which was released over the holiday weekend.
"We reiterate Outperform rating and $275 target price following TSLA’s announcement it delivered over 10k vehicles during Q1 beating both our/Street delivery estimates as well as TSLA’s guidance," Baird analyst Ben Kallo said in a note this morning. "We see a string of positive catalysts ahead. We would be buyers and TSLA remains our favorite pick."
Kallo also praised the increased transparency on display by the company, "We think their decision to change reporting is just as good as the delivery beat. TSLA will now report deliveries within three days of the end of each quarter. This is a good decision as it will reduce speculation and erroneous reports of demand during the month between the end of the quarter and quarterly report."
Brad Erickson of Pacific Crest Securities also reiterated his outperform rating.
"We continue to believe that TSLA shares have weathered undue pessimism recently on account of oil pricing, woes in China, longer-term competitive concerns and skepticism around execution risk."

Please share this article

DCP Midstream Partners, LP (NYSE: DPM)

DCP Midstream Partners, LP owns, operates, acquires, and develops a portfolio of midstream energy assets in the United States. It operates through three segments: Natural Gas Services, natural gas liquids (NGL) Logistics, and Wholesale Propane Logistics. The company’s Natural Gas Services segment gathers, compresses, treats, processes, transports, stores, and sells natural gas. The NGL Logistics segment engages in producing, fractionating, transporting, storing, and selling NGLs, and recovering and selling condensate. The Wholesale Propane Logistics segment is involved in transporting, storing, and selling propane in wholesale markets. It serves retail and wholesale propane customers, refining and petrochemical companies, and NGL marketers operating in the liquid hydrocarbons industry. DCP Midstream GP, LP serves as the general partner of the company.
Take a look at the 1-year chart of DCP (NYSE: DPM) below with my added notations:
1-year chart of DCP (NYSE: DPM)
DPM has formed a clear support at $35 (green). In addition, the stock is declining against a short-term, down trending resistance level (red) over the last couple of months. These two levels combined have DPM stuck within a common chart pattern known as a descending triangle. Eventually, the stock will have to break one of those levels.

The Tale of the Tape: DPM has a down trending resistance and a $35 support level to watch. A long trade could be made on a breakout through the resistance or on a pullback to $35. A break below the $35 support would be an opportunity to enter a short trade.
Please share this article

David Stockman – Yes, Western Government’s Do Plan to Steal Money as the Financial System Collapses

from King World News
Today David Stockman, the man President Ronald Reagan called upon along with Dr. Paul Craig Roberts to help save the United States from disaster in 1981, warned King World News that, yes, Western governments do plan to steal money from their citizens as the financial system implodes. Stockman also spoke about what is really happening with the global economy and why efforts to deceive the public have finally reached the limit.
Eric King: “David, we’re going to take a trip down the rabbit hole of something that’s quite terrifying for people. You’ve read the interviews from King World News with James Turk. He spoke about the ECB and bankrupt Western governments stealing people’s money right out of the banks. This has already unfolded in Cyprus.
Continue Reading at KingWorldNews.com…
Please share this article

Time To Jump Into Russia? :RSX

Please share this article